Article Text

Download PDFPDF
X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene
  1. R Jalkanen2,
  2. M Mäntyjärvi3,
  3. R Tobias4,
  4. J Isosomppi1,
  5. E-M Sankila5,
  6. T Alitalo2,
  7. N T Bech-Hansen4
  1. 1The Folkhälsan Institute of Genetics, Department of Molecular Genetics, Helsinki, Finland
  2. 2Biomedicum Helsinki, Department of Obstetrics and Gynecology, Department of Medical Genetics, Helsinki University Central Hospital, Helsinki, Finland
  3. 3Department of Ophthalmology, University of Kuopio, Kuopio, Finland
  4. 4Departments of Medical Genetics and Surgery, University of Calgary, Calgary, Alberta, Canada
  5. 5Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
  1. Correspondence to:
 Professor Tiina Alitalo
 Helsinki University Central Hospital, Department of OB/GYN, Genetics, Haartmaninkatu 2, PO Box 140, Helsinki, 00029 HUS, Finland; Tiina.Alitalo{at}hus.fi

Abstract

Background: X linked cone-rod dystrophy (CORDX) is a recessive retinal disease characterised by progressive dysfunction of photoreceptors. It is genetically heterogeneous, showing linkage to three X chromosomal loci. CORDX1 is caused by mutations in the RPGR gene (Xp21.1), CORDX2 is located on Xq27.2-28, and we recently localised CORDX3 to Xp11.4-q13.1. We aimed to identify the causative gene behind the CORDX3 phenotype.

Methods: All 48 exons of the CACNA1F gene were screened for mutations by DNA sequencing. RNA from cultured lymphoblasts and peripheral blood activated T lymphocytes was analysed by RT-PCR and sequencing.

Results: A novel CACNA1F mutation, IVS28-1 GCGTC>TGG, in the splice acceptor site of intron 28 was identified. Messenger RNA studies indicated that the identified mutation leads to altered splicing of the CACNA1F transcript. Aberrant splice variants are predicted to result in premature termination and deletions of the encoded protein, Cav1.4 α1 subunit.

Conclusion:CACNA1F mutations cause the retinal disorder, incomplete congenital stationary night blindness (CSNB2), although mutations have also been detected in patients with divergent diagnoses. Our results indicate that yet another phenotype, CORDX3, is caused by a mutation in CACNA1F. Clinically, CORDX3 shares some features with CSNB2 but is distinguishable from CSNB2 in that it is progressive, can begin in adulthood, has no nystagmus or hyperopic refraction, has only low grade astigmatism, and in dark adaptation lacks cone threshold and has small or no elevation of rod threshold. Considering all features, CORDX3 is more similar to other X chromosomal cone-rod dystrophies than to CSNB2.

  • CORDX, X linked cone-rod dystrophy
  • CSNBX, congenital stationary night blindness
  • ERG, electroretinogram
  • PBMC, peripheral blood mononuclear cell
  • VDCC, voltage dependent L-type calcium channel
  • CACNA1F
  • CORDX3
  • CSNB2
  • mutation analysis
  • X linked cone-rod dystrophy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 27 February 2006

  • This research was funded by the Finnish State grant TYH1338, the Finnish Eye and Tissue Bank Foundation, the Foundation Fighting Blindness - Canada, and Canadian Institutes of Health Research. NTBH is the Roy and Joan Allen Professor of Sight Research at the University of Calgary.

  • Competing interest: none declared